FDA Says That Moderna’s Vaccine Booster for COVID Improves the Disease-Fighting Response

FDA Says That Moderna’s Vaccine Booster for COVID Improves the Disease-Fighting Response

Plenty of people are already interested in the COVID vaccine booster from Moderna. Those who received the standard two-dose regimen of the vaccine can get even more protection after a third dose. A recent review from the Food and Drug Administration (FDA) found that a booster shot of Moderna’s vaccine for COVID improved the antibodies responsible for fighting the disease in those individuals who got their previous vaccine doses at least six months earlier, as The Washington Post reveals.

However, the FDA review emphasized that the utility of the booster will depend on some factors that aren’t clear for the moment. The researchers wrote, as quoted by The Washington Post:

Overall, data indicate that currently US-licensed or authorized COVID-19 vaccines still afford protection against severe COVID-19 disease and death in the United States.

The FDA authorized a third COVID shot of the vaccine developed by Pfizer when it comes to certain groups of people – those who are at least the age of 65 years old, those who are at risk of severe illness, as well as those who are in environments where exposure to the coronavirus is higher than usual.

According to information brought by Our World in Data, 47.7% of the world’s population has been vaccinated for COVID with at least one of the needed doses. Only 2.5% of those who live in low-income countries have been vaccinated with at least one of the doses.

What do you think about the news? Would you receive three shots of Moderna’s vaccine for COVID? Feel free to leave us a comment!





Jeffrey Olmsted

Jeffrey likes to write about health and fitness topics, being a champion fitness instructor in the past.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.